Cargando…
Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach
Neoadjuvant chemotherapy (NACT) outcomes vary according to breast cancer (BC) subtype. Since pathologic complete response is one of the most important target endpoints of NACT, further investigation of NACT outcomes in BC is crucial. Thus, identifying sensitive and specific predictors of treatment r...
Autores principales: | Díaz, Caridad, González‐Olmedo, Carmen, Díaz‐Beltrán, Leticia, Camacho, José, Mena García, Patricia, Martín‐Blázquez, Ariadna, Fernández‐Navarro, Mónica, Ortega‐Granados, Ana Laura, Gálvez‐Montosa, Fernando, Marchal, Juan Antonio, Vicente, Francisca, Pérez del Palacio, José, Sánchez‐Rovira, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297806/ https://www.ncbi.nlm.nih.gov/pubmed/35338693 http://dx.doi.org/10.1002/1878-0261.13216 |
Ejemplares similares
-
Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer
por: Díaz-Beltrán, Leticia, et al.
Publicado: (2021) -
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020) -
Novel Biomarkers to Distinguish between Type 3c and Type 2 Diabetes Mellitus by Untargeted Metabolomics
por: Jimenez-Luna, Cristina, et al.
Publicado: (2020) -
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2019) -
Untargeted Metabolomics for the Diagnosis of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis
por: Díaz, Caridad, et al.
Publicado: (2021)